Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Birgit Knoechel, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Birgit Knoechel and Jens Lohr.
Connection Strength

3.532
  1. Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes. J Autoimmun. 2013 Sep; 45:15-23.
    View in: PubMed
    Score: 0.545
  2. Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia. 2022 Apr; 36(4):1078-1087.
    View in: PubMed
    Score: 0.245
  3. Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nat Cell Biol. 2021 11; 23(11):1199-1211.
    View in: PubMed
    Score: 0.241
  4. Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clin Cancer Res. 2021 12 01; 27(23):6432-6444.
    View in: PubMed
    Score: 0.240
  5. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL. Blood. 2021 05 06; 137(18):2463-2480.
    View in: PubMed
    Score: 0.234
  6. Tracking myeloma tumor DNA in peripheral blood. Best Pract Res Clin Haematol. 2020 03; 33(1):101146.
    View in: PubMed
    Score: 0.213
  7. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing. Leukemia. 2018 08; 32(8):1838-1841.
    View in: PubMed
    Score: 0.188
  8. Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease. Semin Hematol. 2018 01; 55(1):33-37.
    View in: PubMed
    Score: 0.187
  9. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Sci Transl Med. 2016 11 02; 8(363):363ra147.
    View in: PubMed
    Score: 0.171
  10. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat Genet. 2014 Apr; 46(4):364-70.
    View in: PubMed
    Score: 0.142
  11. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014 Jan 13; 25(1):91-101.
    View in: PubMed
    Score: 0.141
  12. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3879-84.
    View in: PubMed
    Score: 0.123
  13. Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes Infect. 2009 Apr; 11(5):589-93.
    View in: PubMed
    Score: 0.101
  14. Balancing autoaggressive and protective T cell responses. J Autoimmun. 2007 Mar-May; 28(2-3):59-61.
    View in: PubMed
    Score: 0.088
  15. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 2006 Dec 25; 203(13):2785-91.
    View in: PubMed
    Score: 0.086
  16. Regulatory T cells in the periphery. Immunol Rev. 2006 Aug; 212:149-62.
    View in: PubMed
    Score: 0.084
  17. Functional and molecular comparison of anergic and regulatory T lymphocytes. J Immunol. 2006 Jun 01; 176(11):6473-83.
    View in: PubMed
    Score: 0.083
  18. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med. 2005 Nov 21; 202(10):1375-86.
    View in: PubMed
    Score: 0.080
  19. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol. 2005 Jul 01; 175(1):21-6.
    View in: PubMed
    Score: 0.078
  20. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol Rev. 2005 Apr; 204:116-27.
    View in: PubMed
    Score: 0.077
  21. Role of B7 in T cell tolerance. J Immunol. 2004 Oct 15; 173(8):5028-35.
    View in: PubMed
    Score: 0.074
  22. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol. 2003 Jul; 4(7):664-9.
    View in: PubMed
    Score: 0.067
  23. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J Immunol. 2008 Mar 01; 180(5):2762-6.
    View in: PubMed
    Score: 0.023
  24. T cell tolerance and autoimmunity. Autoimmun Rev. 2004 Nov; 3(7-8):471-5.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.